Sign in

Gavin Eric Parsons

Research Analyst at UBS Asset Management Americas Inc.

Gavin Eric Parsons is currently a Director at UBS in the Aerospace and Defense Equity Research team, focusing on in-depth analysis and coverage of leading companies within the aerospace and defense sector. While specific companies covered are not detailed in available sources, his area of expertise centers on high-growth aerospace and defense contractors, likely including firms similar to HEICO Corporation, based on his engagement with their investor relations events. There is no public evidence of detailed performance metrics such as TipRanks rankings, success rates, or documented returns generated on investment calls. Parsons has built his career at UBS, with previous experience not explicitly outlined in accessible sources; his LinkedIn profile would provide a more comprehensive career timeline and details on prior firms. Professional credentials, including FINRA registration or securities licenses, are not publicly available, and no notable awards, rankings, or public recognitions have been identified in current records.

Gavin Eric Parsons's questions to HEXCEL CORP /DE/ (HXL) leadership

Question · Q3 2025

Gavin Eric Parsons asked if Hexcel's margins in 2026 could exceed those of 2024, assuming higher commercial aerospace revenue. He also questioned Hexcel's contingency plans if destocking by OEMs were to continue longer than anticipated.

Answer

Tom Gentile, CEO, Chairman, and President, confirmed that 2026 margins could be higher, though efforts are needed to offset natural inflation. He explained that Hexcel manages destocking by deliberately lagging hiring decisions until demand materializes and by utilizing existing inventory as a buffer for unexpected increases.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts